Clinical Trials

NCT06187038 | RECRUITING | NA

92 participants

Effects of Including a Chronic Pain Neuroscience Education Program for Individuals With Knee OA

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2024-05-28

Completion:

2026-11-30

Conditions

• Osteoarthritis, Knee

Interventions

• OTHER

No Results Yet

NCT06186843 | ACTIVE_NOT_RECRUITING | NA

25 participants

Plant-based Diet for Kidney Transplant Recipients

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2024-02-29

Completion:

2027-03-25

Conditions

• Kidney Disease, Chronic
• Transplant Complication
• Hypertension
• Diabetes Mellitus
• Metabolic Syndrome
• Inflammation
• Kidney Transplant Failure
• Dietary Habits

Interventions

• BEHAVIORAL

No Results Yet

NCT06186622 | COMPLETED | PHASE1

50 participants

A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2024-01-02

Completion:

2024-07-10

Conditions

• Healthy
• Obese
• Overweight

Interventions

• DRUG

Results Available

NCT06182423 | COMPLETED | NA

57 participants

Chronic Pain Self-management for Older Adults With Cognitive Impairment: A Randomized Pilot Trial

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2024-06-25

Completion:

2025-06-11

Conditions

• Chronic Pain
• Cognitive Impairment

Interventions

• BEHAVIORAL

Results Available

NCT06174116 | RECRUITING | PHASE4

50 participants

Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2024-04-02

Completion:

2026-12-31

Conditions

• Schizophrenia
• Schizo Affective Disorder

Interventions

• DRUG

No Results Yet

NCT06171802 | COMPLETED | PHASE4

206 participants

EMPagliflozin After Aortic Valve Replacement

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2024-02-14

Completion:

2026-05-08

Conditions

• Aortic Valve Stenosis

Interventions

• DRUG

No Results Yet

NCT06170788 | RECRUITING | PHASE3

614 participants

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2023-12-15

Completion:

2028-01-25

Conditions

• Non-small Cell Lung Cancer (NSCLC)

Interventions

• BIOLOGICAL
• DRUG

No Results Yet

NCT06161025 | RECRUITING | PHASE2/PHASE3

860 participants

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2024-02-27

Completion:

2028-02-29

Conditions

• Solid Cancer

Interventions

• DRUG

No Results Yet

NCT06159595 | COMPLETED | NA

11 participants

Behavioral and Neuronal Correlates of Human Mood States

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2023-12-01

Completion:

2025-11-07

Conditions

• Major Depressive Disorder
• Epilepsy

Interventions

• DEVICE

No Results Yet

NCT06152575 | RECRUITING | PHASE3

492 participants

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2024-02-08

Completion:

2026-08-30

Conditions

• Multiple Myeloma

Interventions

• DRUG

No Results Yet

NCT06149481 | RECRUITING | PHASE1/PHASE2

60 participants

Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2024-03-26

Completion:

2027-10-31

Conditions

• Metastatic Colorectal Cancer

Interventions

• DRUG
• BIOLOGICAL

No Results Yet

NCT06129981 | WITHDRAWN | NA

0 participants

TREATMENT OF POST-TRAUMATIC STRESS DISORDER USING AUGMENTED IMAGINATION EXPOSURE PSYCHOTHERAPY WITH VOCAL FEEDBACK: AN ACCEPTABILITY STUDY

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2023-11-30

Completion:

2026-08-31

Conditions

• Post-traumatic Stress Disorder

Interventions

• BEHAVIORAL

No Results Yet

NCT06127030 | RECRUITING | NA

60 participants

Brief Behavioral Teacher Training for Behavioral Difficulties

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2023-12-13

Completion:

2026-10-04

Conditions

• Behavioral Difficulties
• Behavioral Problem of Child

Interventions

• BEHAVIORAL

No Results Yet

NCT06126614 | RECRUITING | PHASE3

21006 participants

Infection Prophylaxis in Total Joint Replacement

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2024-05-07

Completion:

2028-11-30

Conditions

• Periprosthetic Joint Infection

Interventions

• DRUG
• OTHER

No Results Yet

NCT06124196 | RECRUITING

80 participants

Wearable Technology to Evaluate Hyperglycemia and HRV in DMD

Study Type:

OBSERVATIONAL

Last Updated:

2026-05-22

Start Date:

2024-03-20

Completion:

2030-02-28

Conditions

• Duchenne Muscular Dystrophy

Interventions

• DEVICE

No Results Yet

NCT06119542 | RECRUITING

30 participants

Endothelial Damage in Major Spine Surgery, Measured by Circulating Syndecan-1: an Observational Study.(GlycOrtho)

Study Type:

OBSERVATIONAL

Last Updated:

2026-05-22

Start Date:

2026-02-28

Completion:

2026-09-30

Conditions

• Spinal Fusion

No Results Yet

NCT06118515 | RECRUITING | PHASE1

12 participants

A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cytomegalovirus

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2025-02-19

Completion:

2026-05-15

Conditions

• Congenital Cytomegalovirus Infection

Interventions

• DRUG

No Results Yet

NCT06115811 | NOT_YET_RECRUITING | NA

20 participants

Radiation Treatment Plan Evaluation Learning Tool Pilot Project

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2026-06-15

Completion:

2028-06-15

Conditions

• Radiation Oncology

Interventions

• BEHAVIORAL

No Results Yet

NCT06115642 | RECRUITING | PHASE1

367 participants

A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX43 in Advanced/Metastatic Solid Tumors

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2023-11-24

Completion:

2026-06-30

Conditions

• Advanced/Metastatic Malignant Solid Tumors

Interventions

• DRUG

No Results Yet

NCT06113809 | RECRUITING | PHASE1

8 participants

Palbociclib and Pembrolizumab in Sarcoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2024-02-01

Completion:

2028-07-31

Conditions

• Sarcoma

Interventions

• DRUG

No Results Yet

NCT06112106 | COMPLETED | NA

83 participants

The Effect of Intelligent Exercise and Ergonomic Recommendations on Surgeon Musculoskeletal Discomfort

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2023-12-13

Completion:

2026-05-05

Conditions

• Occupational Injuries
• Occupational Exposure

Interventions

• BEHAVIORAL

No Results Yet

NCT06103838 | RECRUITING | PHASE2

60 participants

18F-Fluciclovine PET/CT in Multiple Myeloma

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2024-03-25

Completion:

2026-12-06

Conditions

• Multiple Myeloma
• Newly Diagnosed Multiple Myeloma (NDMM)
• Relapsed and/or Refractory Multiple Myeloma (RRMM)

Interventions

• DRUG
• PROCEDURE

No Results Yet

NCT06102252 | COMPLETED | NA

60 participants

Combination Chemotherapy of Paclitaxel and Carboplatin With or Without Anthracycline as Aneo Adjuvant Treatment in Advanced Endometrial Carcinoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2024-08-15

Completion:

2025-11-01

Conditions

• Endometrial Carcinoma

Interventions

• DRUG

No Results Yet

NCT06098872 | WITHDRAWN | PHASE2

0 participants

Pilot Study on Trametinib for Surgical Unruptured AVMs

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2024-01-30

Completion:

2026-03-26

Conditions

• Arteriovenous Malformations

Interventions

• DRUG

No Results Yet

NCT06092333 | RECRUITING | PHASE2

50 participants

VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2025-01-31

Completion:

2028-02-29

Conditions

• Chronic Hepatitis B

Interventions

• DRUG

No Results Yet

NCT06090669 | RECRUITING | PHASE1

75 participants

Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2023-12-19

Completion:

2026-10-30

Conditions

• Inherited Bone Marrow Failure Syndrome
• Familial Platelet Disorder With Predisposition to Myeloid Malignancies

Interventions

• DRUG
• DEVICE

No Results Yet

NCT06090201 | RECRUITING

200 participants

Severe Congenital Hemostatic Defects, Cerebral MIcrobleeds and COGnition

Study Type:

OBSERVATIONAL

Last Updated:

2026-05-22

Start Date:

2023-11-10

Completion:

2026-08-10

Conditions

• Cerebral Microbleeds, Congenital Haemophilia, Congenital Von Willebrand Disease

Interventions

• OTHER

No Results Yet

NCT06084884 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2

94 participants

A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2023-12-14

Completion:

2027-12-13

Conditions

• Hepatocellular Carcinoma

Interventions

• BIOLOGICAL

No Results Yet

NCT06077864 | ACTIVE_NOT_RECRUITING | PHASE3

5531 participants

A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2023-11-20

Completion:

2026-05-08

Conditions

• Obesity

Interventions

• COMBINATION_PRODUCT

No Results Yet

NCT06075953 | RECRUITING | PHASE2

400 participants

DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2024-02-17

Completion:

2028-11-30

Conditions

• Ductal Carcinoma in Situ

Interventions

• DRUG

No Results Yet

NCT06067438 | RECRUITING | PHASE2

90 participants

Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2024-06-21

Completion:

2027-08-30

Conditions

• Atrial Fibrillation
• Esophageal Carcinoma

Interventions

• DRUG
• OTHER

No Results Yet

NCT06066138 | RECRUITING | PHASE1

30 participants

A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2025-11-04

Completion:

2027-01-31

Conditions

• Locally Advanced Alveolar Soft Part Sarcoma
• Metastatic Alveolar Soft Part Sarcoma
• Locally Advanced Non Small Cell Lung Cancer
• Metastatic Non Small Cell Lung Cancer
• Locally Advanced Small Cell Lung Cancer
• Metastatic Small Cell Lung Cancer
• Locally Advanced Hepatocellular Carcinoma
• Metastatic Hepatocellular Carcinoma
• Locally Advanced Melanoma
• Metastatic Melanoma

Interventions

• DRUG

No Results Yet

NCT06062420 | ACTIVE_NOT_RECRUITING | PHASE2

316 participants

A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2023-11-14

Completion:

2026-09-01

Conditions

• Neoplasms, Head and Neck

Interventions

• DRUG

No Results Yet

NCT06056102 | RECRUITING | PHASE1

20 participants

CAR-T Cell Therapy for Desensitization in Kidney Transplantation

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2024-05-09

Completion:

2028-12-15

Conditions

• Kidney Transplant
• Kidney Failure
• End Stage Renal Failure on Dialysis

Interventions

• DRUG
• BIOLOGICAL

No Results Yet

NCT06054698 | COMPLETED | PHASE2

61 participants

Efficacy and Safety of HRS9531 Injections in Overweight or Obese Subjects

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2023-10-16

Completion:

2024-09-09

Conditions

• Overweight or Obesity

Interventions

• DRUG

No Results Yet

NCT06053216 | COMPLETED | NA

60 participants

Indirect Calorimetry Guided Energy Provision in Critically Ill Patients With Obesity

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2023-10-16

Completion:

2025-11-03

Conditions

• Critical Illness
• Obesity

Interventions

• OTHER

No Results Yet

NCT06050252 | RECRUITING | PHASE2

27 participants

Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2024-07-10

Completion:

2027-02-12

Conditions

• Resectable Intrahepatic Cholangiocarcinoma

Interventions

• PROCEDURE
• DRUG
• BIOLOGICAL

No Results Yet

NCT06044935 | RECRUITING | NA

100 participants

Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2024-01-08

Completion:

2027-01-31

Conditions

• Overweight
• Obesity

Interventions

• OTHER
• DIETARY_SUPPLEMENT

No Results Yet

NCT06043817 | RECRUITING | PHASE1/PHASE2

345 participants

First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2023-09-26

Completion:

2029-12-01

Conditions

• Non-Small Cell Lung Cancer
• NSCLC
• EGFR/HER2 Exon 20 Insertion Mutation

Interventions

• DRUG

No Results Yet

NCT06041503 | RECRUITING | PHASE2

68 participants

Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE)

Study Type:

INTERVENTIONAL

Last Updated:

2026-05-22

Start Date:

2026-01-20

Completion:

2027-10-01

Conditions

• Adenocarcinoma of the Bladder
• Squamous Cell Carcinoma of the Bladder
• Testicular Germ Cell Tumors

Interventions

• DRUG

No Results Yet